5. Литература

Поставить закладку

1. Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107(1):265-276
2. Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124-4130
3. World Health Organization. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008
4. Поддубная И.В., Пробатова Н.А., Семенова А.А. Анапластическая крупноклеточная лимфома. М.: Медиа Медика, 2010.
5. Salaverria I, Bea S, Lopez-Guillermo A, et al. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas. Br J Haematol. 2008;140(5):516-526
6. Мустафаев Д.М., Свистушкин В.М., Цагадаева С.Б., Карпова А.Н. Т-клеточная лимфома назального типа. Вестник оториноларингологии. 2010;6:70-72
7. Toro JR, Liewehr DJ, Pabby N, et al. Gammadelta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood. 2003;101(9):3407-3412
8. Suzumiya J, Ohshima K, Tamura K, et al. The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project. Ann Oncol.2009;20(4):715-721
9. Schmitz N, Trumper L, Ziepert M, et al. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German HighGrade Non-Hodgkin Lymphoma Study Group. Blood. 2010;116:3418-3425
10. d’Amore F, Relander T, Lauritzsen GF, et al. High-dose chemotherapy and autologuos stem cell transplantation in previously untreated peripheral T-cell lymphomaVfinal analysis of a large prospective multicenterstudy (NLG-T-01). J Clin Oncol. 2012 Sep 1;30(25):3093-3099
11. You JY, Chi KH, Yang MH, Chen CC, et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol 2004;15:618-625
12. Yamaguchi M, Kwong YL, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.J Clin Oncol. 201120;29(33):4410-4416
13. Jaccard A, Gachard N, Marin B, Rogez S, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood. 2011;117(6):1834-1839

Для продолжения работы требуется Registration

Предыдущая страница

Следующая страница

1. Методология написания рекомендаций

2. Определение и эпидемиология

3. Классификация и диагностика +

4. Лечение +

5. Литература

Данный блок поддерживает скрол*

5. Литература

Table of contents